Summit Securities Group’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$80.3K Buy
2024
Q4
Sell
2024
Q3
$0 Buy
2023
Q1
Sell
2022
Q4
$0 Buy
2015
Q1
Sell
2014
Q4
$10K Buy
2013
Q3
Sell
2013
Q2
$3K Buy